Experienced in Colitis

Andreas Carstensen-Nordholm

Hillerod, DK 
Experienced in Colitis
Hillerod, DK 
OverviewLocationsClinical Research

Overview

Andreas Carstensen-Nordholm practices in Hillerod, Denmark. Mr. Carstensen-Nordholm is rated as an Experienced expert by MediFind in the treatment of Colitis. His top areas of expertise are Anal Fissure, Gastrointestinal Fistula, Colorectal Cancer, Endoscopy, and Fasciotomy.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Hillerod, Denmark
Other Locations
Copenhagen, Denmark
Roskilde, Denmark
Koge, 4600, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
Treatment Of Chronic Anal Fissure (TOCA): a Randomized Clinical Trial on Levorag® Emulgel Versus Diltiazem Gel 2%
Treatment Of Chronic Anal Fissure (TOCA): a Randomized Clinical Trial on Levorag® Emulgel Versus Diltiazem Gel 2%
Enrollment Status: Terminated
Publish Date: January 14, 2020
Intervention Type: Drug, Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

43 Total Publications

Faecal calprotectin as a non-invasive marker of Crohn's disease in anal fistulas.
Faecal calprotectin as a non-invasive marker of Crohn's disease in anal fistulas.
Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Published: November 17, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Carstensen-Nordholm's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile